Importer of Controlled Substances Application: Sharp (Bethlehem), LLC, 54612 [2018-23705]
Download as PDF
<![CDATA[
54612
Federal Register / Vol. 83, No. 210 / Tuesday, October 30, 2018 / Notices
Convention, 12601 Twinbrook Parkway,
Rockville, Maryland 20852–1717,
applied to be registered as an importer
of the following basic class of the
controlled substance:
Controlled
substance
Drug code
Oxymorphone .........
9652
Schedule
II
The company plans to import the bulk
controlled substance for distribution of
analytical reference standards to its
customers for research and analytical
purposes.
Dated: October 22, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–23701 Filed 10–29–18; 8:45 am]
BILLING CODE 4410–09–P
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on August
30, 2018, Sharp (Bethlehem), LLC, 2400
Baglyos Circle, Bethlehem,
Pennsylvania 18020, applied to be
registered as an importer of the
following basic class of controlled
substances:
Controlled
substance
DEPARTMENT OF JUSTICE
Gamma Hydroxybutyric Acid.
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Sharp (Bethlehem), LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 29, 2018. Such
persons may also file a written request
for a hearing on the application on or
before November 29, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated
his authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
khammond on DSK30JT082PROD with NOTICES
DATES:
VerDate Sep<11>2014
19:27 Oct 29, 2018
Jkt 247001
Drug code
2010
Schedule
I
The company plans to import dosage
forms of the listed controlled substances
to conduct clinical trials.
Approval of permit applications will
occur only when the registrant’s activity
is consistent with what is authorized
under to 21 U.S.C. 952 (a)(2).
Authorization will not extend to the
import of FDA approved or nonapproved finished dosage forms for
commercial sale.
Dated: October 22, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–23705 Filed 10–29–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Fisher Clinical Services,
Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 29, 2018. Such
persons may also file a written request
for a hearing on the application on or
before November 29, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.34(a), this is notice that on August
17, 2018, Fisher Clinical Services Inc.,
7554 Schantz Road, Allentown,
Pennsylvania 18106, applied to be
registered as an importer of the
following basic classes of controlled
substances:
Controlled
substance
Drug code
Psilocybin .........
Methylphenidate
Levorphanol ......
Noroxymorphone.
Tapentadol ........
Schedule
7437
1724
9220
9668
I
II
II
II
9780
II
DATES:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
The company plans to import the
listed controlled substances for clinical
trials.
Dated: October 22, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–23702 Filed 10–29–18; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\30OCN1.SGM
30OCN1
]]>Agencies
[Federal Register Volume 83, Number 210 (Tuesday, October 30, 2018)]
[Notices]
[Page 54612]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23705]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Sharp (Bethlehem),
LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before November 29, 2018.
Such persons may also file a written request for a hearing on the
application on or before November 29, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
The Attorney General has delegated his authority under the
Controlled Substances Act to the Administrator of the Drug Enforcement
Administration (DEA), 28 CFR 0.100(b). Authority to exercise all
necessary functions with respect to the promulgation and implementation
of 21 CFR part 1301, incident to the registration of manufacturers,
distributors, dispensers, importers, and exporters of controlled
substances (other than final orders in connection with suspension,
denial, or revocation of registration) has been redelegated to the
Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on August
30, 2018, Sharp (Bethlehem), LLC, 2400 Baglyos Circle, Bethlehem,
Pennsylvania 18020, applied to be registered as an importer of the
following basic class of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.......... 2010 I
------------------------------------------------------------------------
The company plans to import dosage forms of the listed controlled
substances to conduct clinical trials.
Approval of permit applications will occur only when the
registrant's activity is consistent with what is authorized under to 21
U.S.C. 952 (a)(2).
Authorization will not extend to the import of FDA approved or non-
approved finished dosage forms for commercial sale.
Dated: October 22, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-23705 Filed 10-29-18; 8:45 am]
BILLING CODE 4410-09-P
